

| Package | Price per Dose | Price | |
|---|---|---|---|
| 360 pills | €0,94 | €337,47 Free shipping | |
| 180 pills | €1,00 | €180,08 | |
| 120 pills | €1,09 | €130,14 | |
| 90 pills | €1,30 | €116,52 | |
| 60 pills | €1,56 | €93,81 | |
| 30 pills | €1,92 | €57,49 | |
| 10 pills | €2,42 | €24,20 | |
| 360 pills | €1,47 | €528,16 Free shipping | |
| 180 pills | €1,51 | €272,39 Free shipping | |
| 120 pills | €1,66 | €199,75 Free shipping | |
| 90 pills | €1,83 | €164,94 | |
| 60 pills | €2,19 | €131,65 | |
| 30 pills | €2,42 | €72,63 | |
| 10 pills | €2,72 | €27,23 | |
| 180 pills | €1,82 | €326,88 Free shipping | |
| 120 pills | €2,06 | €246,67 Free shipping | |
| 90 pills | €2,33 | €210,35 Free shipping | |
| 60 pills | €2,50 | €149,81 | |
| 30 pills | €2,72 | €81,71 | |
| 10 pills | €3,03 | €30,25 |
Disclaimer: This information is intended to support, not replace, discussion with a qualified healthcare professional. It explains general information about clomiphene citrate and Clomid in the context of ordinary clinical use in the Netherlands.
Since the 1960s, clomiphene citrate has been used to stimulate ovulation in women with irregular or absent ovulation. This opening fact grounds the reader in the long-standing role of this medication within fertility care and its real-world relevance for trying to conceive. The active ingredient is clomiphene citrate, which is marketed under the brand name Clomid in many settings.
Clomiphene citrate is a member of a drug class known as selective estrogen receptor modulators (SERMs). These medicines can affect estrogen signaling differently in various tissues; specifically, they can block estrogen receptors in some tissues while allowing estrogen-like effects in others. This selective action is central to how Clomid promotes ovulation in appropriate patients.
In practical terms, Clomid is used under medical supervision to help trigger the release of an egg when the regular monthly cycle does not produce ovulation on its own. The Netherlands context typically involves a fertility specialist guiding the treatment plan, with pharmacy dispensing following a medical prescription.
Clomid may require a prescription depending on local rules, and the exact details of preparation and dosing are provided by the prescribing clinician and the official product information. Patients should rely on the official leaflet and their healthcare team for specifics about their situation.
The primary indication for clomiphene citrate is infertility caused by irregular or absent ovulation, known medically as anovulatory infertility. This situation occurs when regular ovulation does not reliably happen in a given cycle, reducing the chance of conception.
Clomiphene citrate is commonly used in individuals diagnosed with polycystic ovary syndrome (PCOS) who have not ovulated regularly. In such cases, the medication is aimed at initiating ovulation and thereby increasing the probability of pregnancy when other factors are not excluded.
The medication may be considered in certain other infertility scenarios where ovulation is a contributing factor, though it is not appropriate for all causes of infertility. A precise diagnosis and an individualized plan are essential, with decisions documented by a fertility specialist.
It is important to note that clomiphene citrate should not be used to address infertility where ovulation is already occurring regularly or as a treatment for non-fertility conditions. For all applications, the treatment plan should be based on a thorough medical assessment.
Clomiphene citrate works by acting on the brain’s control centers for reproductive hormones. It blocks estrogen receptors in the hypothalamus, a region that senses estrogen levels and helps regulate the menstrual cycle. This receptor blockade tricks the brain into perceiving a lower estrogen signal than is actually present.
Because the brain interprets lower estrogen activity, it increases the release of gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to produce more follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These signals stimulate the ovarian follicles, leading to follicle growth and eventual ovulation.
As a selective estrogen receptor modulator (SERM), clomiphene citrate produces tissue-specific effects; the same molecule may block estrogen receptors in the brain while having different actions elsewhere. This means responses can vary between individuals, and not every patient will ovulate in the same way.
In simple terms, Clomid nudges the body toward a hormonal cascade that encourages ovulation by temporarily altering estrogen signaling in the brain, thereby encouraging the ovaries to release an egg. The process is designed to work within a natural monthly cycle, with monitoring by a clinician to assess response.
The exact dose and the number of treatment cycles are determined by the prescriber based on the individual’s diagnosis, reproductive history, and response to therapy. This means that dosing is individualized and may differ from person to person.
The tablets are taken by mouth with a full glass of water. They are typically administered as a short course during a specific window of the menstrual cycle, as directed by the clinician. Food may be used to ease stomach upset, but local instructions should be followed exactly.
To promote consistency and monitoring, the same daily timing is often recommended, unless otherwise advised. If a dose is missed, guidance should be sought from a pharmacist or prescriber, as timing can influence effectiveness and safety. Do not change the dose or duration without professional advice.
Some patients may require routine tests or ultrasound examinations during therapy to assess follicular development and to determine whether ovulation has occurred. It is essential to adhere to follow-up appointments and to report any unexpected symptoms promptly.
Several conditions or circumstances may make clomiphene citrate unsuitable. A thorough medical history is necessary to identify any exclusions.
Other conditions such as severe uncontrolled thyroid or adrenal disorders, or a history of thromboembolism, may require specialist consideration before use. The prescribing clinician will evaluate individual risk factors and determine suitability.
It should be noted that this overview does not replace professional assessment. If any contraindication is present or suspected, consult a healthcare professional before starting therapy.
In the Netherlands, decisions about eligibility for Clomid should be guided by a fertility specialist and supported by the official patient information leaflets provided with the medicine.
Several precautions are important to minimize risk and optimize outcomes. Regular medical supervision increases the likelihood of timely detection of adverse effects or insufficient response.
A known or emerging risk during Clomid therapy is ovarian hyperstimulation, which can manifest as abdominal discomfort, swelling, or rapid weight gain. Any new or worsening abdominal symptoms should be reported promptly.
Clomiphene citrate may increase the chance of multiple pregnancies, including twins or higher-order pregnancies. The potential health implications for both the pregnant person and the fetus require careful counseling and monitoring.
Visual disturbances, such as blurred vision or seeing spots, are rare but can occur. If any visual changes develop, the treatment should be re-evaluated by the clinician. If dizziness or severe headaches occur, consulting a healthcare professional is advised.
Other cautions include ensuring ongoing monitoring of liver function in those with pre-existing liver conditions, and reviewing all medications for interactions that could affect effectiveness or safety. The official leaflet and clinician guidance should be consulted for a complete safety profile.
It is important to avoid unverified self-adjustments to therapy. If pregnancy occurs or if there is no ovulation within the expected timeframe, contact the prescribing clinician for guidance. Urgent medical attention should be sought for severe symptoms or signs of a medical emergency.
Like many medicines, clomiphene citrate can cause a range of adverse effects, most of which are mild to moderate and reversible after discontinuation or dose adjustment. It is important to report persistent or troublesome symptoms to a healthcare professional.
Most side effects are self-limiting or respond to dose adjustments under medical supervision. Any side effect that is persistent, worsening, or concerning should be discussed with a pharmacist or the prescribing clinician.
In the Netherlands, the official patient information leaflets accompanying Clomid will detail all known adverse effects and the recommended steps if they occur.
Interactions can alter how Clomid works or increase the risk of side effects. All medicines, including over-the-counter products and herbal supplements, should be disclosed to the prescribing clinician.
To minimize risk, inform the pharmacist about all prescription medications, non-prescription drugs, vitamins, and supplements being taken. Changes to therapy should not be made without professional guidance.
In the Netherlands, local practice emphasizes careful coordination between the prescribing clinician and the online pharmacy to ensure safety throughout the treatment course.
Clomiphene citrate is not used to sustain pregnancy and should not be used during pregnancy if pregnancy is already established. If pregnancy is suspected, the treatment is usually paused and appropriate prenatal care is pursued under medical supervision.
Information on breastfeeding while taking clomiphene citrate is limited, and decisions should be guided by a clinician, weighing maternal and infant safety considerations. In general, use during lactation should be discussed with a healthcare professional.
For individuals planning pregnancy after stopping Clomid, discussions about timing of attempts and future fertility planning may occur with the treating clinician. Information provided by the official leaflets should be consulted for any pregnancy-related safety notes.
Any unexpected pregnancy during treatment must be communicated to the clinician promptly, as soon as the pregnancy is recognized, to ensure appropriate care and monitoring.
Yes, Clomid is used under medical supervision to support ovulation and increase the chances of pregnancy in women with specific ovulatory problems. The decision is based on clinical assessment and monitoring.
When a dose is missed or a cycle is skipped, guidance should be sought from the prescribing clinician or pharmacist. Do not double dose to make up for a missed day; timing and dosing are important for safety and effectiveness.
Clomid can often be taken with or without food, depending on tolerance and the clinician’s advice. If stomach upset occurs, taking the medication with food may help.
Ovulation may occur within the same cycle in many patients, but individual responses vary. Regular monitoring is used to determine success and to decide on further cycles if needed.
Clomiphene citrate is typically used for a limited number of treatment cycles under medical supervision. Prolonged or repeated use requires careful assessment of risks and benefits, with decisions guided by the clinician.
Contact should be made if pregnancy occurs, if severe or persistent side effects develop, or if no ovulation or no pregnancy occurs after a reasonable treatment window. Seek urgent medical help for any signs of a medical emergency.
Moderate alcohol consumption may not be strictly contraindicated, but excessive alcohol use can affect fertility and overall safety during treatment. Discuss alcohol use with a clinician for personalized guidance.
Clomiphene citrate is primarily used for female infertility related to ovulation. It is not a standard treatment for male infertility, and any use in men should be based on a clinician’s evaluation.
After stopping therapy, normal menstrual cycles may resume, but the timing and pattern can vary. A clinician can provide guidance on what to expect and how to monitor for ovulation in subsequent cycles.
It is important to discuss all medications with the treating clinician, as some drugs may interact with clomiphene citrate or affect response. Do not stop or start medicines without professional advice.
The official patient information leaflet accompanying Clomid and the guidance of a fertility specialist or pharmacist provide the most reliable sources. If questions arise, consult the prescribing clinician or a licensed pharmacist for clarification.
The primary source of detailed, product-specific information is the official patient information leaflet supplied with the medicine. This document covers indications, dosing, side effects, warnings, and storage details in the context of the product as manufactured.
Questions about suitability, dosing adjustments, or monitoring requirements should be discussed with a fertility specialist or the dispensing pharmacist. They can tailor information to the individual’s medical history and current health status.
Additional reliable references include the pharmacist’s guide, hospital-based fertility clinics, and national health service guidance in the Netherlands. The clinician who prescribes Clomid can provide written materials, contact information, and instructions for follow-up appointments.
In case of uncertainties, check the official leaflet or consult a healthcare professional to clarify any aspect of use, dosing, timing, or safety. Seek urgent medical help if there are signs of a medical emergency or severe adverse effects.
14–21 days. Free from €182,34 .
5–9 days. €27,35
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
